<code id='DC519B5C88'></code><style id='DC519B5C88'></style>
      • <acronym id='DC519B5C88'></acronym>
      <center id='DC519B5C88'><center id='DC519B5C88'><tfoot id='DC519B5C88'></tfoot></center><abbr id='DC519B5C88'><dir id='DC519B5C88'><tfoot id='DC519B5C88'></tfoot><noframes id='DC519B5C88'>
      • <optgroup id='DC519B5C88'><strike id='DC519B5C88'><sup id='DC519B5C88'></sup></strike><code id='DC519B5C88'></code></optgroup>
        5. <b id='DC519B5C88'><label id='DC519B5C88'><select id='DC519B5C88'><dt id='DC519B5C88'><span id='DC519B5C88'></span></dt></select></label></b><u id='DC519B5C88'></u>
          <i id='DC519B5C88'><strike id='DC519B5C88'><tt id='DC519B5C88'><pre id='DC519B5C88'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / Wikipedia / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-10-06 07:31:30 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：859
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Readout LOUD podcast: 2023 in review, and a look at biotech in 2024
                                
                            
          Next article：  
                                      
                                          DIEP, the 'gold standard' of breast reconstruction, is under threat
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles